Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 May 2024 | Story Dr Nitha Ramnath | Photo right
UFS - Thought-Leader Webinar

2024 UFS Thought-Leader Webinar Series

PRESENTS

a webinar titled

2024 Elections: Promises, Perils, and Delivery: What the Future Holds After 29 May 2024?


The University of the Free State (UFS) is pleased to present its first webinar for the year, titled 2024 Elections: Promises, Perils, and Delivery: What the Future Holds After 29 May 2024? – which is part of the 2024 Thought-Leader Webinar Series. As a public higher-education institution in South Africa with a responsibility to contribute to public discourse, the university will be presenting the webinar as part of the UFS Thought-Leader Series, which is in its sixth consecutive year.  The aim of the webinar series is to discuss issues facing South Africa by engaging experts at the university and in South Africa.

 

Webinar presented on 23 May 2024

On 29 May 2024, South Africans will go to the polls. This election is considered by South Africans as significant and much needed since the end of apartheid in 1994. South Africa is plagued by record power cuts, poor service delivery, and high levels of unemployment, with drastic effects on businesses and the local economy. Coinciding with the celebration of 30 years of freedom and democracy, this seventh democratic election is a turning point for South Africa to determine the desired future for all South Africans.

Date:   Thursday 23 May 2024

Time: 12:30-14:00

RSVP:  Click to view document HERE no later than 22 May 2024.

Some of the topics discussed by leading experts in 2023 included, among others, Threats to South Africa’s stability and security challenges; The need for a global and regional plan / approach to respond to the consequences of the Russia-Ukraine war; and Student protest action, politics, and higher education.


Facilitator:

 

Prof Francis Petersen

Vice-Chancellor and Principal, UFS

 

Panellists:

Prof Bonang Mohale

Chancellor, UFS

 

Dr Ebrahim Harvey

Political writer and commentator

 

Bios of speakers:

Prof Bonang Mohale

Prof Bonang Mohale is the Chancellor of the University of the Free State, former President of Business Unity South Africa (BUSA), Professor of Practice in the Johannesburg Business School (JBS) College of Business and Economics, and Chairman of two listed entities – the Bidvest Group Limited and ArcelorMittal, as well as SBV Services and Swiss Re Corporate Solutions! He is a member of the Community of Chairpersons (CoC) of the World Economic Forum and author of two best-selling books, Lift As You Rise and Behold The Turtle! He has been included in the Reputation Poll International’s (RPI) 2023 list of the ‘100 Most Reputable Africans’. The selection criteria are integrity, reputation, transparency, visibility, and impact. He is the recipient of the 2023 ME-Vision Academy’s ‘Exclusive Recognition in Successful Leadership’ Award for consistently leading self successfully, consistently leading people successfully, successfully leading as a senior executive and CEO, successfully leading society in various impactful roles, and his contribution to mentoring and inspiring future successful leaders.

 

Dr Ebrahim Harvey

Dr Ebrahim Harvey is a political writer, analyst, commentator, former Cosatu trade unionist, and Mail & Guardian columnist. He is currently a News24 columnist. He also wrote the authorised biography of former president, Kgalema Motlanthe (2012), and The Great Pretenders: Race and Class under ANC Rule (2021), which won the 2022 SA Literary Award for Non-Fiction. He holds a master’s degree in Public and Development Management and a PhD degree in Sociology, both from the University of the Witwatersrand.

News Archive

HIV Cure – Just another fantasy?
2016-07-27

Description: HIV Cure – Just another fantasy? Tags: HIV Cure – Just another fantasy?

Dr Dominique Goedhals, Prof John Frater,
Dr Thabiso Mofokeng and Dr Jacob Jansen van Vuuren,
attended the lecture. Prof Frater has been working in
collaboration with the UFS Department of Internal
Medicine on HIV resistance and HIV immunology
since 2007.

Photo: Nonsindiso Qwabe

Twenty-years ago, after a person had been diagnosed with HIV, their lifespan did not exceed three years, but thanks to the success of antiretroviral therapy programmes, life expectancy has risen by an average of ten years. However, is antiretroviral therapy always going to be for life? This is the societal issue that Professor John Frater, addressed in his talk at the University of the Free State. He is an MRC Senior Clinical Fellow, Associate Professor and Honorary Consultant Physician in Infectious Diseases at  Oxford University.

Antiretroviral medicine therapeutic

The discovery of antiretroviral therapy - the use of HIV medicines to treat the virus - has had a positive effect on the health and well-being of people living with it, improving their quality of life. Unfortunately, if treatment is stopped, HIV rebounds to the detriment of the patient. Now, research has shown that some patients, who are treated soon after being infected by HIV, may go off treatment for prolonged periods. Work is being done to predict who will be able to stop treatment.

“The difference made by starting treatment earlier is enormous. Delaying treatment is denying yourself the right to health,” Professor Frater says. However, this does not mean that the virus is cured. “A person can live for ten years without being on HIV treatment, but is that enough?” he went on to ask.

Healthy lifestyles encouraged

The National Department of Health will adopt a test and treat immediately strategy later this year to improve patient health and curb the spread of HIV. ,This is another reason why everybody should know their status and start treatment as soon as possible.

Search for a cure continues

More research is being conducted to establish whether HIV can be eradicated. Remission gives hope that a permanent cure may be found eventually. “Will a cure for HIV ever be found? Time will tell,” he concluded.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept